Category: CEO

The Cure for Cancer and Eric Lefkofsky

There is approximately forty percent of adults in the USA alone, who have dealt with cancer in their lifetime, and even more that have had a loved one that endured it. Approximately nineteen million by the year 2024. Thanks to a company called Tempus now, things are looking up. Eric Lefkofsky is the co-founder of this data-enabled precision medical group.

 His inspiration came after realizing the lack of care for cancer treatment that should be in place. His wife, who had recently been diagnosed with breast cancer, needed treatment. So, he created Tempus. The goals were set fairly high, but the outcomes were lifechanging. They developed a platform wherein a patient could be analyzed for data to help with the proper line of treatment to get well and learn more about Eric.

The changes that came afterward were an uphill climb for Tempus. They had a struggle trying to get data to be accessible to the software that they had created to analyze. Even that didn’t stand in their way. The data was captured via the notes in a manner to be analyzed successfully, and Tempus was now ahead of the game and more information click here.

The advances that were added including the human genome for analysis, which, with the genome now successfully mapped, could be better analyzed for diagnosis of the correct treatment plan. The only problem was the cost. It still was far from cost effective treatment. The treatments ran into the millions.

The clinical information is valuable though. It offers that chance that has been lacking in the medical field today to be properly analyzed for the effective treatment and even prevention of some cancers.

Eric graduated from the University of Michigan Ann Arbor, where his work was so impressive, that he graduated with full honors. Considering the work he has done to create software to analyze the human genome, it goes without saying that he is admirable. He had worked as a teacher prior to his research and worked as a professor at DePaul University Kellstadt Graduate School of Business and also at Northwestern.

 His life had a side turn when his wife had to deal with breast cancer, and obviously, it has changed his path forever by creating Tempus. His research could one day be in the hall of fame for medical advances and Eric’s lacrosse camp.

Scott Rocklage’s Successful Venture in the Healthcare Industry

Scott Rocklage has been the managing partner of 5AM Venture Management LLC since 2004. He joined 5AM Ventures in 2003 as a Venture Partner.

He has over 30 years of experience in the management of healthcare, and he is also an expert in strategic management that has led the FDA approval of three drugs in U.S.

Scott M. Rocklage studied at the University of California where he pursued B.S in Chemistry. He pursued his PhD at MIT where he studied Chemistry and did his research in Richard R. Schrocks’ Laboratory.

He has served EPIRUS Biopharmaceutical, Inc as its CEO since July 2016 and has also served as a chairman of various boards, including Rennovia Inc.

Scott Rocklage joined 5AM Ventures investors who founded the company that used to be called Bay City Capital. After Scott joining the team, the company showed an upward trend. Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift and http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY

This is because he was responsible for seeing that the drugs were approved, infrastructures, where the drugs can be launched, were built and he developed a strong pipeline.

5AM Ventures is one of the big venture capital company that is determined to build next-generation life science companies that will have a capacity of giving high returns to investors.

They support companies that are trying to solve health care problems by use of science and medicine.

5AM Ventures’ success can be attributed to the fact that it has a team of specialized professional that have strong operational, legal, scientific, medical, and financial expertise.

This helps the company to find, determine, and shape portfolio companies. 5AM Ventures also tries to help these companies in areas of management recruiting, strategy, fundraising, and business development.

Dr Rocklage has been in the forefront in the leadership of 5AM Ventures. In his position, he has assisted many companies that are attached to 5AM group by enabling to treat various diseases.

5AM’s success is greatly attributed to the leadership of Dr Rocklage. He has an excellent approach to solving scientific problems and also, he is an expert in choosing the right company to work with. He is the best asset for 5AM Venture!

Read more:

Idea Mensch | Scott Rocklage